2.1
Finerenone (Kerendia, Bayer) is indicated 'for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults'.
2 Information about finerenone
Marketing authorisation indication
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics for finerenone.
Price
2.3
The list price of finerenone is £36.68 for 28 tablets, for both the 10‑mg and 20‑mg doses. The daily cost of treatment is £1.31 (BNF online, accessed January 2023). Costs may vary in different settings because of negotiated procurement discounts.